Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

China flag China · Delayed Price · Currency is CNY
12.90
-0.20 (-1.53%)
Jun 11, 2026, 3:04 PM CST
Market Cap2.06B -9.0%
Revenue (ttm)260.58M +0.1%
Net Income56.04M +7.6%
EPS0.35 +9.5%
Shares Out 160.00M
PE Ratio36.77
Forward PEn/a
Dividend0.30 (2.29%)
Ex-Dividend DateMay 29, 2026
Volume1,828,992
Open13.15
Previous Close13.10
Day's Range12.64 - 13.15
52-Week Range12.64 - 20.36
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China. [Read more]

Sector Healthcare
Founded 1998
Employees 309
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300519
Full Company Profile

Financial Performance

In 2025, SHE:300519's revenue was 265.36 million, a decrease of -0.86% compared to the previous year's 267.66 million. Earnings were 54.21 million, an increase of 7.58%.

Financial Statements